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Background: Dicranopteris linearis (family Gleicheniaceae) has been reported to possess anti-inflammatory and
antioxidant activities but no attempt has been made to study its hepatoprotective potential. The aim of the present
study was to determine the hepatoprotective effect of methanol extracts of D. linearis (MEDL) against
carbon tetrachloride (CCl4)-induced acute liver injury in rats.
Methods: 6 groups (n = 6) of rats received oral test solutions: 10% dimethyl sulfoxide (DMSO), 200 mg/kg silymarin,
or MEDL (50, 250, and 500 mg/kg), once daily for 7 consecutive days, followed by hepatotoxicity induction with
CCl4. Blood and liver were collected for biochemical and microscopic analysis. The extract was also subjected to
antioxidant studies (e.g. 2, 2-diphenyl-1-picrylhydrazyl (DPPH)- and superoxide anion-radical scavenging assays,
oxygen radical absorbance capacity (ORAC) test and total phenolic content (TPC) determination), phytochemical
screening and HPLC analysis.
Results: Pretreatment with MEDL and silymarin significantly (P < 0.05) reduced the serum levels of AST, ALT and
ALP, which were increased significantly (P < 0.05) in DMSO-pretreated group following treatment with CCl4.
Histological analysis of liver tissues in groups pretreated with MEDL and silymarin showed mild necrosis and
inflammation of the hepatocytes compared to the DMSO-pretreated group (negative control group). The MEDL
showed higher DPPH- and superoxide anion-radical scavenging activity as well as high TPC and ORAC values
indicating high antioxidant activity.
Conclusions: MEDL exerts hepatoprotective activity that could be partly contributed by its antioxidant activity and
high phenolic content, and hence demands further investigation.
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The liver has a pivotal role in regulating many important
functions, such as metabolism, secretion, storage; and
plays a role in regulating various physiological processes
[1]. Furthermore, it is involved in detoxification of a var-
iety of drugs and xenobiotics and thereforeat increased
susceptible to the toxicity from these agents. It is fre-
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unless otherwise stated.widely exposed to environmental toxins, prescribed and
over-the-counter drugs, which cause various liver dis-
eases [2]. Liver diseases have become aworldwide prob-
lem as a result of extremely poor prognosis and high
mortality due to the lack of effective prevention or drug
available that stimulates liver function, offer protection
against liver damage, or help to regenerate hepatic cells
[3,4]. Therefore, attempts are perpetually being made to
discover new treatment for liver disease, and the discov-
ering process have been paid great attention to the in-
vestigation of the efficacy of plant-based drugs used in
traditional medicine as they are cheap and have littlel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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world population relies mainly on plant-based drugs [5].
In lieu of the aforementioned problem, patients suffer-
ing from liver diseases have turned to complementary
and alternative medicine (CAM), which includes among
others the use of herbal medicines as their sources of
hepatoprotective agents. According to White et al. [6],
over 50% of patients that required health care used
CAM either in conjunction with, or separate from, con-
ventional health care. Despite its uses for treatment of
various types of diseases, the use of CAM is also popular
in patients with liver disease but is not well documented
[6]. According to Bhawna and Kumar [7], hepatoprotec-
tive plants contain a variety of phytochemicals like phe-
nols, coumarins, monoterpenes, glycosides, alkaloids,
and xanthenes. In addition, hepatoprotective properties
are related with phytoextracts or phytocompounds rich
in natural antioxidants as reported from previous studies
[8-10]. One of the plants that have been studied exten-
sively in our laboratory for its medicinal potentials is
Dicranopteris linearis (L. (Gleicheniaceae), locally known
as “resam”, is common in secondary forests and grows
well in poor clay soil [11]. D. linearis has been used in
Malay traditional medicine to reduce body temperature
and to control fever [12]. In addition, there are few re-
ports of its traditional uses in other parts of the world,
with only 2 reports describing its use to treat external
wounds, ulcers, and boils by the people of Papua New
Guinea, to eliminate intestinal worms by the people of
Indochina, and to treat asthma and female sterility by
the tribes living on an Indian mountain [13]. Scientific-
ally, the leaf extracts of D. linearis have been reported to
possess antinociceptive, anti-inflammatory and antipyr-
etic [12], gastroprotective [14], antistaphylococcal [15],
antioxidant [16], and anticancer activities [17]
properties.
The present study was performed based on three reasons,
namely: i) the previous reports on the anti-inflammatory
and antioxidant activities of D. linearis leaves; ii) the reports
linking the anti-inflammatory and antioxidant activities to
the hepatoprotective mechanism [3,18,19], and; iii) no sci-
entific report to date to prove on the hepatoprotective po-
tential of D. linearis leaves. It is postulated that D. linearis
leaves will exert hepatoprotective activity that could be
linked to its antioxidant activity. Therefore, the aim of the
present study was to determine the hepatoprotective activ-
ity of methanol extract of D. linearis (MEDL) using the
carbon tetrachloride (CCl4)-induced acute liver damage
in rats model. In addition, the antioxidant activity, phyto-
chemical content and HPLC profile of MEMM were also
verified to support the hepatoprotective potential of MEDL.
The hepatoprotective potential of the MEDL was compared
with silymarin, a known, commercially available hepatopro-
tective agent.Methods
Collection of plant material
The plant material (D. linearis) was obtained from its nat-
ural habitat in Serdang, Selangor, Malaysia. The plant was
authenticated by Dr. Shamsul Khamis, a botanist at the
Institute of Bioscience (IBS), Universiti Putra Malaysia
(UPM), Serdang, Selangor, Malaysia, and voucher speci-
men SK 1987/11 was deposited in the herbarium of the
IBS, UPM. The leaves were shade-dried for a week at
room temperature (27 ± 2°C) and powdered mechanically.
Preparation of plant extract
The powdered dried leaves were weighed (160 g) and
then soaked (72 hours; room temperature) in methanol
in the ratio of 1:20 (w/v). The solutions were collected
and filtered with cotton wool followed by Whatman No.
1 filter paper. This procedure was repeated three times.
Then, the collected supernatant was pooled together and
evaporated using a rotary vacuum evaporator at 40°C
under reduced pressure. The evaporation of the MEDL
resulted in a yield of 48.4 g (30.3%). The crude dried ex-
tract obtained was kept at 4°C prior to use.
Phytochemical screening
The phytochemical screening was carried out to deter-
mine the presence of alkaloids, saponins, flavonoids, hy-
drolysable and condensed tannins, triterpenes and steroids
according to the method described by Ikhiri et al. [20].
Analyses were performed based on 5 g of dried powder
material and 100 mg of extract (organic).
HPLC analysis of MEDL
The HPLC analysis of MEDL was performed according
to the previous report [21] but with slight modifications.
Briefly, 10 mg of MEDL was dissolved in 1 ml methanol
and then filtered through the membrane filter (pore
size 0.45 μm). A Waters Delta 600 with 600 Controller
and Waters 2996 Photodiode Array (Milford, MA, USA)
equipped with an autosampler, online degasser and
column heater was used to analyze the filtered sample.
Data was evaluated and processed using the installed
Millenium 32 Software (Waters Product). The filtered
samples were separated at 27°C on a minibore Phenom-
enex Luna 5 μm C18 column (dimensions 250 × 4.60 mm)
using a one-step linear gradient. The solvents were (A)
0.1% aqueous formic acid and (B) acetonitrile and the elu-
tion system was as follows: Initial conditions were 85% A
and 15% B with a linear gradient reaching 25% B at
t = 12 minutes. This was maintained for 10 minutes after
which the programme returned to the initial solvent com-
position at t = 25 minutes and continued for 10 minutes.
The flow rate used was 1 ml/min and the injection volume
was 10 μl. The chromatogram was monitored at 254 and
366 nm. In addition, the extract was also spiked with pure
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grams obtained were compared to the chromatograms of
the pure standards of flavonoids, respectively.
Antioxidant activity of MEDL
Total phenolic content
Total phenolic contents (TPC) of all plant extracts were
determined using Folin-Ciocalteu reagent as described
by Singleton and Rossi [22] with slight modifications.
Methanolic solution of the extract in the concentration
of 1 mg/ml was used in the analysis. In brief, 1 mg
MEDL was extracted with 1 ml 80% methanol contain-
ing 1% hydrochloric acid and 1% distilled water at room
temperature on the shaker set at 200 rpm for 2 hours.
Then, the mixture was centrifuged at 2817 × g for 15 mi-
nutes and supernatant decanted into vials. The reaction
mixture was prepared by mixing 200 μl supernatant ex-
tract, 400 μl (0.1 ml/0.9 ml) Folin-Ciocalteu reagent and
allowed to stand at room temperature for 5 minutes.
Then, 400 μl sodium bicarbonate (60 mg/ml) solution
was added and the mixture was allowed to stand at
room temperature for 90 minutes. The absorbance was
determined using a spectrophotometer at 725 nm. A
calibration curve was generated by using the gallic acid
standard optical density, and the levels in the samples
were expressed in terms of gallic acid equivalent (GAE) -
TPC mg/100. Based on the measured absorbance, the
concentration of phenolics was read (mg/ml) from the
calibration line.
DPPH radical scavenging activity
The ability of MEDL to induce free radicals scavenging
action was determined using the 2, 2-diphenyl-1-picryl-
hydrazyl (DPPH) assay according to the method of Blois
[23] but with modifications involving the use of a high-
throughput microplate system. Forty microliters of ex-
tracts (1 mg/ml) were mixed with 50 μl DPPH (FG:
384.32) (1 mM in ethanolic solution) and 150 μl absolute
ethanol on a 96-well microtiter plate in triplicate. The
96-well microtiter plate was shaken for 15 seconds at
500 rpm. Then, the plate was left to stand at room
temperature for 30 minutes and the absorbance was re-
corded at 520 nm.
Superoxide anion radical scavenging
The ability of MEDL to induce the superoxide anion
radicals scavenging action was measured according to
the method described by Liu et al. [24] with slight modi-
fications. Briefly, the superoxide radicals are produced
in phenazine methosulphate - nicotinamide adenine di-
nucleotide (PMS – NADH) systems via oxidation of
NADH and evaluated by the reduction of nitroblue
tetrazolium (NBT). In these experiments, the superoxide
radicals were produced in 3 ml of Tris-HCl buffer(16 mM, pH 8) containing 1 ml of NBT (50 μM), 1 ml
NADH (78 μM) and MEDL (25 – 50 μg). The reaction
was started by adding 1 ml of PMS solution (10 μM) to
the mixture. The reaction mixture was incubated at 25°C
for 5 minutes, the absorbance was read at 560 nm using
a spectrophotometer (Schimadzu UV-Vis 1700) against
blank samples using l-ascorbic acid as a control. De-
creased absorbance of the reaction mixture indicated
increasing superoxide anion scavenging activity. The per-
centage inhibition of superoxide anion production was
evaluated using the following formula:
% inhibition ¼ AC−ATð Þ=AC½   100
where AC was the absorbance of the control (l- ascorbic
acid), and AT was the absorbance in the presence of
MEDL or standards.
Oxygen radical absorbance capacity
The antioxidant capacity of MEDL was also determined
using the oxygen-radical absorbance-capacity (ORAC)
assay as described by Huang et al. [25], with some modi-
fications. In the assay, 2, 2-azobis (2-amidinopropane)
dihydrochloride (AAPH) was dissolved in 10 ml of
75 mM phosphate buffer (pH 7.4) which was prepared
daily as peroxyl-radical generator. A fluorescein stock
solution (1 mM) was prepared in 75 mM phosphate buf-
fer (pH 7.4) and stored in wrapping foil at 5°C. During
the analysis, the sodium fluorescein stock solution was
diluted 1: 100 000 with 75 mM phosphate buffer
(pH 7.4). The microplate wells were filled with 150 μl of
working solution of sodium fluorescein and 25 μl of
Trolox dilution in blank wells, or with 25 μl of MEDL
extracts in sample wells and then was equilibrate by incu-
bating for 10 minutes at 37°C. After the solutions equili-
brated, 25 μl of 240 m M AAPH solution was added to
the wells to initiate the reactions. BMG Omega Fluostar
Fluorescent Spectrophotometer (Company, state & coun-
try) with injector was used with an excitation filter of
485 nm and an emission filter of 520 nm. The fluores-
cence intensity of each well was then measured kinetically
with data taken every one minute for 3 hours. ORAC
values were calculated using MARS Data Analysis Reduc-
tion Software.
Animals
Male Sprague Dawley rats (180-200 g; 8-10 weeks old)
and male ICR mice (25-30 g; 5-7 weeks old) were ob-
tained from the Veterinary Animal Unit, Faculty of Vet-
erinary Medicine, Universiti Putra Malaysia (UPM),
Malaysia and were housed at room temperature (27 ± 2°C;
70 – 80% humidity; 12 h light/darkness cycle) in the
Animal Holding Unit (UPM). They were supplied with
food and water ad libitum from the beginning of the
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current UPM guidelines for the care of laboratory ani-
mals and the ethical guidelines for investigations of
experimental pain in conscious animals. All experiments
were conducted between 09.30 and 18.30 h to minimize
the effects of environmental changes. The study protocol
of the present study was approved by the Animal House
and Use Committee, Faculty of Medicine and Health
Sciences, UPM (Ethical approval no.: UPM/FPSK/PADS/
BR-UUH/00449).
Hepatoprotective assay
Carbon tetrachloride-induced hepatotoxicity test
For this in vivo study, male Sprague-Dawley rats weigh-
ing 180–200 g were used. The animals were kept in sep-
arate cages with ad libitum access to food and water in
a room with controlled temperature (22 ± 3°C) and on a
12-hour light/dark cycle with lights switched on at
7:00 a.m. The animals were divided into 6 groups com-
prising 6 rats in each group as described below:
 Group I: only 10% DMSO orally (p.o.) for 7 days +
50% olive oil on day 7
 Group II: 10% DMSO p.o. for 7 days + CCl4 on
day 7
 Group III: 200 mg/kg silymarin p.o. for 7 days +
CCl4 on day 7
 Group IV, V, and VI: 50, 250, and 500 mg/kg of
MEDL p.o. for 7 days + CCl4 on day 7
Each group received respective dose of the solution and
extract once daily for 7 consecutive days. We administered
1 ml/kg of 50% CCl4 on day 7 to all animals except Group
1 and animals were sacrificed by exposure to diethyl ether
48 hours after administration of CCl4. Three millilitres of
blood were collected by cardiac puncture. Blood samples
were collected into lithium heparinized tubes using a ster-
ile disposable syringe for biochemical analysis. After 20 -
minutes, the blood was separated by centrifugation for
10 minutes at 1000 × g using a refrigerated centrifuge.
Following centrifugation, the plasma was transferred into
a clean polypropylene tube and stored at -80°C. Liver was
removed from rats and weighed.
Biochemical analysis
Biochemical parameters were assayed according to standard
methods. The enzymes alanine aminotransferase (ALT),
alkaline phosphatase (ALP), and aspartate aminotransferase
(AST) were measured using a Hitachi 902 Automatic
Chemical Analyser.
Histopathology
After the liver tissue was fixed in 10% formalin, speci-
mens were embedded in paraffin, sectioned (3–5 μm),and stained with hematoxylin and eosin. The histochem-
ical sections were evaluated under an electron microscope
and evaluated by a pathologist according to the severity of
the hepatic injury as described by El-Beshbishy et al. [26]
with modifications.
Statistical analysis
All the data are presented as mean ± SEM. Statistical
analysis was performed using GraphPad Prism version 5.
Data obtained were analyzed using the one-way analysis
of variance and the differences between groups and the
control group were determined using Dunnett’s post hoc
test with P < 0.05 as the limit of significance.
Results
Phytochemical screening of MEDL
Phytochemicals screening of D. linearis was carried out
using two types of samples, which are the powdered leaf
and MEDL. From the results obtained, several phytocon-
stituents were detected. Only saponins, flavonoids, tan-
nins and polyphenolic compounds, steroids, but not
alkaloids, were detected in the respective leaves and
MEDL. In comparison to MEDL, the leaves of D. linearis
show no presence of triterpenes at all.
HPLC analysis of MEDL
In an attempt to establish the HPLC profile of MEDL,
the extract underwent the HPLC analysis at several
wavelengths of which the peaks were clearly separated at
the wavelengths of 254 and 366 nm (Figure 1A). At
366 nm, in particular, four major peaks were clearly de-
tected in the chromatogram at the respective retention
time (RT) of 19.76, 20.36, 21.29, and 23.32 minutes, re-
spectively. Further analysis demonstrated that the four
peaks showed λmax values in the region of 228-349, 234-
350, 254-350 and 264-347 nm, respectively (Figure 1B).
The extract spiked with either rutin or quercitrin was
found to share the same peak, respectively, indicating
their presence in the MEDL (Figure 1A).
Antioxidant activity of MEDL
For total phenolic content, the absorbance values re-
sulted from the reaction between the extract solution
and Folin-Ciocalteu reagent was compared to the stand-
ard solutions of GAE; the results of the colorimetric ana-
lysis of the TPC of the MEDL was 1757.25 ± 29.39 mg
GAEs/g extract. According to the standard procedure,
any extract with the TPC value of >1000 mg GAEs/g ex-
tract is considered to have high TPC value. At the con-
centration of 200 μg/ml, the MEDL caused 98.94 ±
1.14% antioxidant activities against DPPH free radical as
compared to the standard drug, 200 μg/ml ascorbic acid.
For the superoxide anion radical scavenging, at the con-
centration of 200 μg/ml, the MEDL caused 93.2 ± 1.81%
AB
Figure 1 The HPLC analysis of MEDL. A. HPLC profile of MEDL at two different wavelength; i) 254 nm, and ii) 366 nm. Attempt was made to
standardize the MEDL using various pure flavonoids standard. Based on the HPLC analysis, rutin and quercitrin was detected in the extract.
B. HPLC profile of MEDL at 366 nm shows four major peaks, labelled as 1, 2, 3 and 4, that was successfully separated. Each peak was represented
by their respective UV-Vis spectra with λmax value of 228-349, 234-350, 254-350 and 264-347 nm, respectively. These ranges of UV-Vis spectra
indicated the presence of flavonoids-types of compounds.
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ical as compared to the standard drug, 200 μg/ml ascor-
bic acid. The ORAC value for 200 μg/ml MEDL, which
is expressed as μM Trolox Equivalent (TE)/100 g, was
24272.50 ± 2056.53.
In vivo hepatoprotective study
Effect of MEDL on the body weight and liver weight after
induction with CCl4
The body and liver weights of the rats after treatments
are shown in Table 1. Overall, there were no significant
differences of body weight and liver weight between the
different experimental groups compared to the negative
control group. However, the rats in the CCl4-intoxicated
group exhibited significantly (P < 0.05) higher liver/body
weight ratio when compared to rats in the vehicle con-
trol group. The administration of MEDL lowered the
liver/body weight ratio and this was comparable to the
effects observed in silymarin-treated rats.
Histopathological study of the CCl4-induced hepatotoxic
liver with and without pretreatment with MEDL
The livers of the normal control rats pretreated with
10% DMSO followed by treatment with 10% DMSO
showed normal histoarchitecture. As seen in Figure 2A,
the liver section of normal rat showed distinct hepatic
cells with well-preserved cytoplasm, prominent nucleus,
hepatocytes radiately arranged around the central vein,
and well-defined sinusoidal line. The liver section of rats
pretreated with 10% DMSO followed by treatment with
CCl4 showed severe cytoplasmic vacuolation, microvesicu-
lar and macrovesicular fatty changes, karyopiknosis, loss
of cellular boundaries, infiltration of inflammatory cells
around the central vein and in the portal areas, congestion
in the sinusoids, and necrosis of the liver cells (Figure 2B).
Interestingly, those observations were markedly amelio-
rated in the groups pretreated with silymarin or MEDL
indicated by significant reduction in the number of
ballooning-degenerated hepatocytes and significant de-
creased in the necrosis area (Figure 2D-2F). In the group
pretreated with 200 mg/kg silymarin followed by CCl4Table 1 Effect of MEDL on percentage change of body and liv
Treatment Dose (mg/kg) Body weight, B
Vehicle - 208.7 ± 5.54
Vehicle + CCl4 - 208.9 ± 6.53
Silymarin + CCl4 200 222.1 ± 4.42
MEDL + CCl4 50 204.6 ± 1.89
250 220.4 ± 5.54
500 209.3 ± 3.33
Values are expressed as means ± S.E.M. of six replicates.
aSignificant different as compared to the normal control group in the respective co
bSignificant different as compared to negative control group in the respective columadministration, only slight steatosis and infiltration of lym-
phocytes and, spotty and focal necrosis were observed
(Figure 2C). Pretreatment with MEDL exhibited a dose-
dependent hepatoprotective effect wherein the group pre-
treated with 50 mg/kg MEDL exerted moderate necrosis
and infiltration of leucocytes with mild steatosis. In the
liver section pretreated with 250 mg/kg MEDL a moderate
damage to the liver’s architecture was seen indicated by
the presence of moderate steatosis with some fatty
changes and mild leucocytes infiltration around the centri-
lobular region (Figure 2E). Figure 2F presents liver section
of the group pretreated with 500 mg/kg MEDL showing
slight necrosis and mild steatosis (Figure 2F). The histo-
patholgical scoring of CCl4-treated rat’s liver sections after
pre-treatment with MEDL is shown in Table 2. The ex-
tract as well as silymarin caused remarkable decrease in
the signs of CCl4-induced toxicity.
Biochemical analysis of blood samples
The changes in serum liver biomarkers are shown in
Table 3. As indicated from the results, CCl4-intoxicated
rats showed a significant (p < 0.05) increased in the ac-
tivities of ALT, AST, and ALP compared to the normal
control group. Pretreatment of rats with high dose of
MEDL or silymarin significantly (p < 0.05) decreased the
level of serum marker enzymes compared to the CCl4-
intoxicated group.
Discussion
CCl4 has been widely used in animal models to investigate
chemical-induced liver injury. The CCl4-induced experi-
mental damage involves the formation of free radicals and
the occurrence of lipid peroxidation in cellular and organ-
elle membranes [27]. CCl4 will be metabolized in the liver
to form highly reactive trichloromethyl free radicals
(·CCl3), which are responsible in triggering the toxicity
processes in the liver. This free radicals are further con-
verted to trichloromethyl peroxyl radical (CCl3OO·) that
act as the initiator of lipid peroxidation [28-30]. The pres-
ence of excessive amount of free radicals accelerate perox-
idative degradation of cellular membrane, which resulteder weight in CCl4- treated rats
W (g) Liver weight, LW (g) LW/BW (%)
6 5. 852 ± 0.2873 2.797 ± 0.0726
9 10.34 ± 0.2623a 4. 969 ± 0.1627a
7.830 ± 0.5425b 3.523 ± 0.2324b
3 8.672 ± 0.2498b 4.237 ± 0.1902b
1 9.335 ± 0.2631b 4.240 ± 0.1020b
6 8.759 ± 0.4539b 4.181 ± 0.1924b
lumn, p < 0.05.
















Figure 2 Liver photomicrographs. A) Vehicle control showed normal architecture of normal liver histology, central vein (CV), hepatocytes (H).
B) Hepatotoxic liver after treatment with CCl4 showing ere necrosis (N) of the hepatocytes in parenchyma region, as well as macrovesicular
steatosis (S). C) Pre-treatment with 200 mg/kg of Silymarin, positive control preserves normal architecture of the hepatocytes. D) Pre-treatment
with 50 mg/kg of MEDL showing mild necrosis with mild infiltration of inflammatory cell E) Pre-treatment with 250 mg/kg of MEDL showing mild
macrovesicular steatosis and absent to few degree of hepatocyte necrosis. F) Pre-treatment with 500 mg/kg of MEDL showing macrovesicular
steatosis around central vein region. H & E staining, 40 × magnifications.
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and AST, and, subsequently, lead to the elevation of serum
ALT and AST levels. Moreover, several remarkable patho-
logical characteristics associated with CCl4-induced hep-
atotoxicity, namely fatty liver, cirrhosis and necrosis, could
be seen and have been thought to result from the forma-
tion ad action of reactive intermediates (i.e trichlorometyl
free radicals (CCl3+) metabolized by the mixed function
cytochrome P450 in the endoplasmic reticulum.
One of the ways to measure the extent of hepatic dam-
age is through the determination of the level of cytoplas-
mic enzymes (i.e. ALT, AST and ALP) that leak into the
blood circulation, which is associated with massive centri-
lobular necrosis, ballooning degeneration and cellular in-
filtration of the liver [31]. Measurement of ALT is more
liver-specific to determine hepatocellular damage [32].
However, measurement of AST is still commonly used to
assess liver function because it is a sensitive indicator ofTable 2 Histopathological scoring of the liver section of CCl4-
Treatment Dose (mg/kg) Steatosis
Vehicle + Vehicle - -
Vehicle + CCl4 ++
Silymarin + CCl4 200 +
MEDL + CCl4 50 ++
250 ++
500 +
The severity of various features of hepatic injury was evaluated based on those foll
severe effect.mitochondrial damage, particularly in centrilobular re-
gions of the liver [33]. According to Ahmed and Khater
[34], transaminase levels return to normal due to the heal-
ing of hepatic parenchyma and the regeneration of hepa-
tocytes. In the present study, CCl4–induced increase in
the liver/body weight ratio indicating that the liver
damage model had been successfully developed. This is
further supported by the increase in the level of serum
ALT, AST and ALP and histological scoring and micro-
scopic findings. Interestingly, pretreatment with MEDL
effectively protected the rodents against CCl4-induced
hepatic intoxication, which are evidenced by significant
reduction in the liver/body weight ratio, levels of serum
liver enzymes. Furthermore, it is well established that
intoxication with CCl4 leads to extensive necrosis in the
liver centrilobular regions around the central veins [9] and
fatty infiltration [35]. Interestingly, the microscopic exam-








owing scoring scheme: - normal, + mild effect, ++ moderate effect, +++
Table 3 Effects of MEDL on serum liver biomarkers of CCl4- treated rats
Treatment Dose (mg/kg) ALT (U/L) AST (U/L) ALP (U/L)
Vehicle - 16.00 ± 2.867 93.18 ± 6.239 114.7 ± 7.055
Vehicle + CCl4 - 4291 ± 665.3
a 3456 ± 633.2a 460.0 ± 49.62a
Silymarin + CCl4 200 249.1 ± 30.68
b 288.1 ± 25.32b 190.2 ± 19.67b
MEDL + CCl4 50 3283 ± 686.5 4291 ± 592.0 350.2 ± 36.80
b
250 1886 ± 134.2b 1853 ± 86.77b 171.8 ± 13.04b
500 2298. ± 359.9b 1850 ± 228.5b 185.8 ± 10.23b
Values are expressed as means ± S.E.M. of six replicates.
aSignificant different as compared to the normal control group in the respective column, p < 0.05.
bSignificant different as compared to negative control group in the respective column, p < 0.05.
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by decreased in histological scoring.
As described earlier, the basis of CCl4-induced liver tox-
icity lies in its biotransformation to free radicals via the
cytochrome P450 system [36]. Since free radicals play
important role in CCl4-induced hepatotoxicity, it seems
rational to suggest that compounds with capability to
neutralize such free radicals might also possess a hepato-
protective activity. In fact, various natural products (e.g ex-
tract of Artemisia campestris and pure compound like
ginsenosides) with antioxidant potential have been reported
to protect against CCl4-induced hepatotoxicity [36]. In
the present study, MEDL was proven to exhibit radicals
scavenging activities using various in vitro antioxidant
models suggesting that the extract perhaps protected the
hepatocytes by ameliorating oxidative stress and inhibiting
lipid peroxidation. In addition, it is also plausible to add
anti-inflammatory activity as another possible mechanism
through which MEDL exerts the hepatoprotective activity.
This suggestion is based on previous reports that D. linearis
possess anti-inflammatory activity, which might explained
the ability of MEDL to reduce inflammation associated with
CCl4 as observed during microscopic examination.
MEDL has also been shown to contain high TPC value,
which have been associated with high antioxidant activity
[37,38] as well as anti-inflammatory activity [39,40]. These
claims are in line with previous findings by Wu et al. [27]
who reported that TPC-rich extract of Laggera pterodonta
exerts both hepatoprotective and antioxidant activities
when assessed using the in vitro primary cultured neo-
natal rat hepatocytes. Adetutu and Owoade [41] also re-
ported that TPC-rich extract of Hisbiscus sabdariffa
exhibits both hepatoprotective and antioxidant activities
when assessed using in vivo CCl4-induced rat hepatotoxic
model. The positive correlations between the high anti-
oxidant activity and high TPC have been reported else-
where [27,41] and are parallel with our findings. Thus,
the antioxidant activity attributed by the presence of
high concentration of TPC in MEDL could be suggested
to play significant role in the observed hepatoprotec-
tive activity. Interestingly, one class of compounds thatcontributed to the highTPC reading is flavonoids, which have
been known to play remarkable role in anti-inflammatory
activity. Flavonoids have been detected in MEDL whereas
MEDL has been shown to attenuate inflammation in
CCl4-induced liver injury. This seems to suggest the
role of anti-inflammatory activity of D. linearis as reported
previously in enhancing the observed hepatoprotective
activity.
Phytochemical analysis of MEDL demonstrated the
presence of several phytocontituents (e.g. flavonoids,
tannins, saponins and triterpenes) essentially associated
with antioxidant and/or hepatoprotective effects. Earlier
studies have claimed that phenolic compounds possess
diverse pharmacological effects (i.e. antioxidant, anti-
inflammatory, and hepatoprotective) [27,30,42]. MEDL
exerted prominent hepatoprotective effects against CCl4-
induced liver damage possibly via the antioxidant- and
anti-inflammatory-modulated mechanisms, which is in
compliance with the description on the pharmacological
properties of phenolic compounds in the aforemen-
tioned reports. HPLC analysis of MEDL demonstrated
the presence of four major peaks with their λmax value
that fall in the region of 192-348.2, 192-349.4, 192-349.4,
and 264.9-347 nm, respectively. Based on report made
by Tsimogiannis et al. (2007), each of the peaks represents
flavonoid-based compounds. According to Tsimogiannis
et al. (2007), flavonoids are divided into several subgroups,
namely flavonols, flavones, dihydroflavonols, flavano-
nols and flavanones based on the UV-Vis spectra within
which they fall. The UV-Vis spectra of flavonoids falls
within two absorbance bands, labeled as Band A and
Band B wherein Band A represents flavones or flavo-
nols and lies in the range of 310–350 nm or 350–
385 nm, respectively. Meanwhile Band B falls in the
range of 250 and 290 nm and is much the same in all
the aforementioned flavonoid subgroups. As for the
flavanones and dihydroflavonols subgroup, Band A falls
between 300–330 nm while Band B was detected in
the range of 277–295 nm. Interestingly, the presence
of low amount of flavonoids in MEDL is concurrent
with the HPLC profile of MEDL that shows only four
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noids such as rutin and quercitrin have been isolated
from D. linearis and, interestingly, rutin and quercitrin
have also been reported to exert antioxidant activity
[43,44] and hepatoprotective activity [44,45]. Hence,
flavonoids, like rutin and quercitrin, in addition to
other polyphenolic constituents may be the prominent
bioactive compounds responsible for antioxidant and
hepatoprotective activities of MEDL.
It is also noteworthy to highlight on the inconsistency
with regards to the presence of low amount of flavonoids
in MEDL as detected in the phytochemical screening
and the high TPC value of MEDL, and to provide pos-
sible explanation for this inconsistency. It is plausible
to suggest that the high TPC value is attributed to the
presence of other types of flavonoids, particularly, the
flavonol 3-O- glycosides [46]. This suggestion, which is
supported by the UV spectra characteristics of major
peaks as detected in the HPLC, is based on the fact that
flavonoid glycosides are soluble in methanol:water and
acetone:water solvent systems, but not very soluble in
water alone [47-49]. With the high presence of saponin
in MEDL, the existence of flavonoids glycosides could be
attributed to the tensioactive effect of saponins, which
are present in relatively high quantities when compared
to the flavonoids [50].
Conclusions
The hepatoprotective potential of MEDL were evaluated
for the first time. The results obtained demonstrated that
MEDL possessed significant protection against CCl4-in-
duced hepatotoxicity, which could be due, partly, to its
high TPC value and, antioxidant and anti-inflammatory
properties through scavenging free radicals to ameliorate
oxidative stress and inhibit lipid peroxidation. Moreover,
phytochemical screening revealed the presence of various
phenolic compounds, with rutin and quercitrin identified,
which may also contribute to the hepatoprotective activity
of MEDL.
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